Exane Derivatives’s Becton Dickinson BDX Stock Holding History
Bought
Maintained
Sold
Other funds holding BDX
Exane Derivatives's BDX Position: Q2 2022 in Review
Exane Derivatives sold out of Becton Dickinson (BDX) in Q2 2022, closing a stake of 74 shares — an estimated $19.2K sold.
Exane Derivatives first reported a position in BDX in Q3 2015 and held it in 19 quarters. The position peaked at $576K in Q3 2021. 1,536 funds tracked by Wall St. Rank hold BDX as of Q2 2022.
- Exane Derivatives reported no remaining Becton Dickinson position as of Q2 2022 after selling out during the quarter.
- Exane Derivatives sold 74 Becton Dickinson shares in Q2 2022, an estimated $19.2K.
- Exane Derivatives first reported a position in Becton Dickinson in Q3 2015 and held it in 19 quarters.
- Exane Derivatives's Becton Dickinson position peaked at $576K in Q3 2021.
- 1,536 funds tracked by Wall St. Rank held Becton Dickinson as of Q2 2022.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.